Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Podcast on Current Questions, Clinical Trials in Adjuvant Therapy for Resected NSCLC
Author
Howard (Jack) West, MD

GRACE is very happy to have the opportunity to present this podcast by Dr. Heather Wakelee, medical oncologist at renowned lung cancer expert at Stanford University Cancer Center. The focus of this particular program, supported by an educational grant from GlaxoSmithKline, is on the most important research questions and clinical trials in the field of post-operative therapy for resected NSCLC.

Here is the video version along with the audio (mp3) version and the accompanying figures and transcript. We'll try to get Dr. Wakelee back for future programs, so if you want to leave questions or comments to her, please do.

[powerpress]

wakelee-on-adjuv-nsclc-clin-qs-trials-figures

wakelee-on-adjuv-nsclc-clin-qs-trials-transcript

wakelee-on-adjuv-nsclc-clin-qs-trials-audio-podcast

Next Previous link

Previous PostNext Post

Related Content

Article
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
Image
2025 Spanish Targeted Therapy in Lung Cancer Patient Forum
Article
Da click aquí para más información y para registrarte ahora

Recent Comments

JOIN THE CONVERSATION
I don't know what to do. No…
By Ascardino on
Hi Hopish hope,  Welcome to…
By JanineT GRACE … on
Thank you for sharing
By LeviDrake on